Alnylam Pharmaceuticals (A1LN34.SA) Q1 1 Earnings

1JanConfirmed
Q1 1
-3.59
-3.5
-3.41
-3.32

Details

Expected EPS
-3.32408
Actual EPS
-3.5936
Surprise EPS
-0.27
Surprise Percent
+8.11%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -3.5936 per share for Q1 1.

0 Comments

Share your thoughts